Studies in insulinoma [14] and CHO cells [24], revealed different potencies of the two peptides, and moreover, stimulation of insulin secretion by TLQP-62 in insulinoma cells was not blocked by the C3aR1 antagonist SB290157 [14]. The gene discussed is C3AR1; the disease is pancreatic insulinoma.